Yayın:
A Design of Experiments‐Based Chiral HPLC Method for the Quantification of Talazoparib and Enantiomeric Purity Determination in Pharmaceutical Formulations

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSakine Atila Karaca
dc.contributor.authorSona Aliyeva
dc.contributor.authorDuygu Yeniceli
dc.contributor.orcid0000-0002-9440-3438
dc.date.accessioned2026-05-20T10:22:00Z
dc.date.issued2026-03-20
dc.identifier.doi10.1002/chir.70094
dc.identifier.endpagee70094
dc.identifier.issn0899-0042
dc.identifier.issue4
dc.identifier.openalexW7139993534
dc.identifier.startpagee70094
dc.identifier.urihttps://hdl.handle.net/11421/39850
dc.identifier.urihttps://doi.org/10.1002/chir.70094
dc.identifier.volume38
dc.language.isoen
dc.relation.ispartofChirality
dc.rightsopenAccess
dc.subjectEnantiomer
dc.subjectPerchloric acid
dc.subjectResolution (logic)
dc.subjectEnantiomeric excess
dc.subjectHigh-performance liquid chromatography
dc.subjectChromatographic separation
dc.subjectRelative standard deviation
dc.titleA Design of Experiments‐Based Chiral HPLC Method for the Quantification of Talazoparib and Enantiomeric Purity Determination in Pharmaceutical Formulations
dspace.entity.typePublication

Dosyalar

Koleksiyonlar

Publications